Regional Variation in Physician Adoption of Antipsychotics: Impact on US Medicare expenditures
Author(s)Donohue, Julie M.; Normand, Sharon-Lise T.; Horvitz-Lennon, Marcela; Men, Aiju; Huskamp, Haiden A.; Berndt, Ernst R; ... Show more Show less
MetadataShow full item record
Background—Regional variation in US Medicare prescription drug spending is driven by higher prescribing of costly brand-name drugs in some regions. This variation likely arises from differences in the speed of diffusion of newly-approved medications. Second-generation antipsychotics were widely adopted for treatment of severe mental illness and for several off-label uses. Rapid diffusion of new psychiatric drugs likely increases drug spending but its relationship to non-drug spending is unclear. The impact of antipsychotic diffusion on drug and medical spending is of great interest to public payers like Medicare, which finance a majority of mental health spending in the U.S.
DepartmentSloan School of Management
The Journal of Mental Health Policy and Economics
Donohue, Julie M. et al. "Regional variation in physician adoption of antipyschotics: Impact on US Medical expenditures." The Journal of Mental Health Policy and Economics, The Journal of Mental Health Policy and Economics 19.2 (2016): 69–78.
Author's final manuscript